
Successful oncolytic virus immunotherapy clinical development requires unique features that focus on viral biology and host immune response.
Successful oncolytic virus immunotherapy clinical development requires unique features that focus on viral biology and host immune response.
Published: February 13th 2025 | Updated: March 4th 2025
Published: February 19th 2025 | Updated: February 26th 2025
Published: March 24th 2023 | Updated:
Published: April 28th 2021 | Updated:
Published: July 26th 2024 | Updated:
Published: January 31st 2024 | Updated: